Skip to main content
SpringerLink
Log in

Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kyle RA, Maldonado JE, Bayrd ED (1974) Plasma cell leukemia. Report on 17 cases. Arch Intern Med 133:813–818

    Article  PubMed  CAS  Google Scholar 

  2. Bernasconi C, Castelli G, Pagnucco G, Brusamolino E (1989) Plasma cell leukemia: a report on 15 patients. Eur J Haematol Suppl 51:76–83

    PubMed  CAS  Google Scholar 

  3. Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102:1115–1123

    Article  PubMed  CAS  Google Scholar 

  4. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609–2617

    Article  PubMed  CAS  Google Scholar 

  5. Jagannath S, Barlogie B, Berenson J, Siegel D, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Adams J, Kauffman M, Esseltine DL, Schenkein DP, Anderson KC (2004) A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol 127:165–172

    Article  PubMed  CAS  Google Scholar 

  6. Esparis-Ogando A, Alegre A, Aguado B, Mateo G, Gutierrez N, Blade J, Schenkein D, Pandiella A, San Miguel JF (2005) Bortezomib is an efficient agent in plasma cell leukemias. Int J Cancer 114:665–667

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, University of Regensburg, 93042, Regensburg, Germany

    J. Grassinger, T. Südhoff & B. Hennemann

  2. Department of Hematology and Oncology, Klinikum Passau, 94032, Passau, Germany

    R. Andreesen

Authors
  1. J. Grassinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Südhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Andreesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Hennemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Hennemann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grassinger, J., Südhoff, T., Andreesen, R. et al. Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib. Ann Hematol 85, 132–133 (2006). https://doi.org/10.1007/s00277-005-0027-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-005-0027-7

Keywords

Search

Navigation